Publication
Title
Time-resolved fluorescence (TRF) for total IgG and HPV16-specific antibody detection in first-void urine and serum : a comparative study
Author
Abstract
Recent studies demonstrated that human papillomavirus (HPV) specific immunoglobulins (IgG) are present and detectable in non-invasively collected first-void urine (FVU) samples. As IgG levels in urine are low, we evaluated the potential of a highly sensitive HPV16-specific assay based on time-resolved fluorescence, DELFIA, and compared it with three immunoassays, GST-L1-MIA, M4ELISA, and M9ELISA. A total of 225 paired serum and FVU samples from two cohorts of healthy female volunteers were analyzed. Strong Spearman rank correlations between HPV16-specific IgG results measured with DELFIA, M4ELISA, GST-L1-MIA, and M9ELISA were found for both sample types (rs > 0.80). Additionally, total human IgG results, determined in all samples using HTRF human IgG kit and BioPlex Pro™ Human Isotyping Assay, were compared. Moderate correlations between total human IgG concentrations in FVU samples were found for the two total IgG assays (rs ≥ 0.42, p < 0.0001), while correlations for serum were non-significant. In conclusion, the HPV16-DELFIA assay is usable for detecting HPV16-specific antibodies in FVU and serum samples. As total human IgG remains an interesting parameter for the normalization of HPV-specific IgG in FVU, the accuracy of both assays needs to be validated further. 1.
Language
English
Source (journal)
Journal of virological methods. - Amsterdam
Publication
Amsterdam : 2024
ISSN
0166-0934
DOI
10.1016/J.JVIROMET.2024.115003
Volume/pages
329 (2024) , p. 1-12
Article Reference
115003
ISI
001292108800001
Pubmed ID
39069158
Medium
E-only publicatie
Full text (Publisher's DOI)
Full text (open access)
UAntwerpen
Faculty/Department
Research group
Project info
Development of a first-void urine based highly sensitive competitive HPV immunoassay.
Biomarkers in first-void urine for improved diagnosis and monitoring
UROSCREEN: a home-based first-void URine One-step triage option for cervical cancer SCREENing.
Exploring the ideal genital tract liquid biopsy: standardization of anti-HPV antibody detection in first-void urine for non-invasive vaccine monitoring.
Disease and vaccine monitoring based on non-invasive genital tract liquid biopsy sampling (URISAMP).
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Record
Identifier c:irua:207383
Creation 20.08.2024
Last edited 22.04.2025
To cite this reference